跳至主要内容
临床试验/NL-OMON46921
NL-OMON46921已完成3 期

ltra-early tranexamic acid after subarachnoid hemorrhage. A prospective, randomized, multicenter study. - ULTRA

Academisch Medisch Centrum0 个研究点目标入组 950 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
950

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Admission to one of the participating study centers or the participating referring hospitals;
  • CT-confirmed SAH with most recent ictus less than 24 hours ago
  • Age 18 years and older

排除标准

  • No proficiency of the Dutch or English language
  • No loss of consciousness after the hemorrhage with World Federation of Neurological Surgeons (WFNS) grade 1 or 2 on admission in combination with a perimesencephalic hemorrhage
  • Bleeding pattern on CT compatible with a traumatic SAH
  • Treatment for deep vein thrombosis or pulmonary embolism
  • History of blood coagulation disorder (a hypercoagulability disorder)
  • Pregnancy checked with a pregnancy test in women in their childbearing period
  • History of severe renal (serum creatinin > 150 mmol/L) failure
  • Imminent death within 24 hours

研究者

相似试验

ltra-early tranexamic acid after subarachnoid... | 临床试验